When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

The findings highlight the importance of rheumatology, cardiology, and primary care working together to intervene early.

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...

The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

Individuals assigned male at birth who were pushed to change their identity had more inflammation and higher blood pressure.